NXL (Nexalin Technology) YoY Rev. per Sh. Growth : 0.00% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Nexalin Technology's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 0.00%.

Nexalin Technology's Revenue per Share for the three months ended in Sep. 2024 was $0.00.

Nexalin Technology YoY Rev. per Sh. Growth Historical Data

The historical data trend for Nexalin Technology's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology YoY Rev. per Sh. Growth Chart

Nexalin Technology Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

-12.12

717.24

-93.67

Nexalin Technology Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial											-97.14	-40.00	175.00	-20.00	-

Nexalin Technology YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Nexalin Technology's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(0.015	-	0.237)	/	\| 0.237 \|
=	-93.67 %

Nexalin Technology's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(0.003	-	0.003)	/	\| 0.003 \|
=	0.00 %

Nexalin Technology YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Nexalin Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

1776 Yorktown, Suite 550, Houston, TX, USA, 77056

Website

https://www.nexalin.com

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Executives

David Owens	director, officer: Chief Medical Officer	4545 HARRIS TRAIL NW, ATLANTA GA 30327
Marilyn Elson	10 percent owner, officer: Ms. Elson serves as CFO	32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad	director	6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White	director, officer: President/CEO	1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
Alan Kazden	director	3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser	other: Spouse
Ben Hu	director	7021 EDGERTON ROAD, NORTH ROYALTON OH 44133